AH
MDCO

Aviva Holdings’s Medicines Co MDCO Stock Holding History

Aviva Holdings’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-115,100
Closed -$5.75M – 6
2019
Q3 		$5.75M Sell
115,100
-867,731
-88% -$34.6M 1.35% 5
2019
Q2 		$35.8M Sell
982,831
-2,795,911
-74% -$91.3M 7.5% 3
2019
Q1 		$106M Hold
3,778,742
– – 23.17% 2
2018
Q4 		$72.3M Hold
3,778,742
– – 22.8% 3
2018
Q3 		$113M Hold
3,778,742
– – 30.15% 2
2018
Q2 		$139M Buy
3,778,742
+405,345
+12% +$13.2M 22.51% 3
2018
Q1 		$111M Buy
3,373,397
+298,095
+10% +$9.31M 45.08% 1
2017
Q4 		$84.1M Sell
3,075,302
-758,697
-20% -$23.4M 49.24% 1
2017
Q3 		$142M Buy
3,833,999
+352,400
+10% +$13M 73.83% 1
2017
Q2 		$132M Sell
3,481,599
-352,300
-9% -$15.7M 83.45% 1
2017
Q1 		$187M Buy
+3,833,899
New +$175M 87.42% 1

Other funds holding MDCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Aviva Holdings's MDCO Position: Q4 2019 in Review

Aviva Holdings sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 115,100 shares — an estimated $5.75M sold.

Aviva Holdings first reported a position in MDCO in Q1 2017 and held it in 11 quarters. The position peaked at $187M in Q1 2017. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Aviva Holdings reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Aviva Holdings sold 115,100 Medicines Co shares in Q4 2019, an estimated $5.75M.
  • Aviva Holdings first reported a position in Medicines Co in Q1 2017 and held it in 11 quarters.
  • Aviva Holdings's Medicines Co position peaked at $187M in Q1 2017.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Aviva Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.